Why the study?
Does combined assessment of cardiac troponin and copeptin improve diagnostic accuracy for early rule-out of acute myocardial infarction compared to cardiac troponin alone in patients with symptoms suggestive of AMI?
Population
15 studies pooling 8,740 patients with symptoms suggestive of acute myocardial infarction (AMI prevalence 16%)
Comparison
Combined assessment of cardiac troponin and… vs Cardiac troponin (cTn) alone
Design
Meta-analysis
Authors
Loading...
Supports combined copeptin-cTn testing for safer early AMI rule-out; confirms meta-analytic value of biomarker combinations in diagnostic triage.
Does combined assessment of cardiac troponin and copeptin improve diagnostic accuracy for early rule-out of acute myocardial infarction compared to cardiac troponin alone in patients with symptoms suggestive of AMI?
Adding copeptin to cardiac troponin significantly improves sensitivity for early rule-out of acute myocardial infarction, though at the cost of reduced specificity.
Raskovalova et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: